Cozad Asset Management Inc. Sells 2,740 Shares of CVS Health Co. (NYSE:CVS)

Cozad Asset Management Inc. trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 21.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,049 shares of the pharmacy operator’s stock after selling 2,740 shares during the quarter. Cozad Asset Management Inc.’s holdings in CVS Health were worth $593,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CVS. USA Financial Formulas lifted its holdings in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. purchased a new position in CVS Health during the 4th quarter worth $32,000. First Community Trust NA grew its stake in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares in the last quarter. Creekmur Asset Management LLC bought a new position in shares of CVS Health during the fourth quarter valued at about $34,000. Finally, Steph & Co. grew its position in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $59.30 on Thursday. The firm has a market cap of $74.44 billion, a price-to-earnings ratio of 10.42, a PEG ratio of 0.80 and a beta of 0.52. The company has a 50-day simple moving average of $58.33 and a two-hundred day simple moving average of $64.04. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The business’s revenue was up 2.6% on a year-over-year basis. On average, equities analysts forecast that CVS Health Co. will post 6.52 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.49%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. Barclays lowered their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. JPMorgan Chase & Co. decreased their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Argus reduced their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Eleven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $72.48.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.